Company overview
Cyagen Biosciences specializes in custom genetically engineered mouse and rat models, including knockout, knockin, conditional knockout, transgenic, and Cre-recombinase strains for genetics, pharmacology, and disease modeling research. They offer integrated preclinical services such as cell and animal model development, viral packaging, and expert-led studies to support drug discovery, validation, and IND applications. Additional products include stem cells like OriCell™ bone marrow mesenchymal stem cells and AAV solutions for gene therapy.
Cyagen Biosciences is listed in the NovaPharmaNews Supplier Hub as a CRO & Clinical Services partner serving United States & Americas. Core focus areas include cyagen, mouse models, rat models, genetically engineered models, preclinical cro, knockout mice.
Industry categories: CRO & Clinical Services. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://www.cyagen.com
- Categories
- CRO & Clinical Services
- Markets served
- United States & Americas
- Keywords
- cyagen, mouse models, rat models, genetically engineered models, preclinical cro, knockout mice, stem cells, aav packaging
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What types of genetically engineered animal models does Cyagen provide?
- Cyagen provides knockout, knockin, conditional knockout, transgenic, Cre-recombinase expressing, and reporter mouse and rat models for research in gene function, disease modeling, pharmacology, and drug safety.
- What preclinical services does Cyagen offer?
- Cyagen offers integrated services including cell and animal model development, viral packaging (e.g., AAV), and expert-led preclinical studies from initial idea through IND-enabling studies.
- Where are Cyagen's facilities and operations located?
- Cyagen is headquartered in Santa Clara, California, with additional locations in Japan and China, and production facilities in China.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
